Diagnostic Challenges in MDS

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: December 17, 2018
Expiration Date: December 17, 2019

Expected time to complete this activity as designed: 30 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

Clinicians face a number of challenges when diagnosing a patient with myelodysplastic syndromes (MDS). In this activity, Dr. Eric Padron discusses the molecular basis of MDS and its requirements for diagnosis. He also explains diagnostic mimics and precursor conditions, and which diagnostic criteria to utilize in your practice.

Target Audience

This activity is designed for multidisciplinary healthcare providers in the community setting, including hematologists, oncologists, pharmacists and other allied healthcare professionals who provide care to patients with myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Differentiate between various classifications of diseases within the MDS spectrum
  • Incorporate clinical guidelines into the diagnostic approach for patients with suspected MDS
  • Utilize evidence-based testing strategies for the accurate and timely diagnosis of MDS

Agenda

Diagnostic Challenges in MDS – Eric Padron, MD

Instructions for Participation and Credit

This activity is eligible for credit through December 17, 2019. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Eric Padron, MD
Assistant Member
Malignant Hematology Department
H. Lee Moffitt Cancer Center
Tampa, Florida

Dr. Eric Padron received his medical degree from the University of Florida in Gainesville. He completed his internal medicine residency at University of Florida, and his hematology/oncology fellowship at Moffitt Cancer Center, University of South Florida. He is an Assistant Member in the Malignant Hematology Department at the H. Lee Moffitt Cancer Center in Tampa, Florida, as well as Section Head of Genomics and Personalized Medicine.

Dr. Padron is a founding member of MDS/MPN International Working Group and is a member of the American Society of Hematology and the American Society of Clinical Oncology. His research focus is in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). His applied translational laboratory seeks to identify and implement novel discoveries directly to the clinic. Dr. Padron has successfully translated his laboratory discoveries into several trials in the CMML clinic. This is exemplified by his bench-to-bedside efforts that have led to the successful completion of a phase 1 and 2 trial testing ruxolitinib in CMML.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.5 contact hours of Continuing Education Credit.
Universal Activity Number: 827-0000-18-050-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Eric Padron has received grant support related to research activities from Humanagen, Incyte Corporation, and Kura Oncology, Inc.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Andrea Mathis, Project Manager, Keith D’Oria, Medical Writer, and Joan Meyer, RN, MHA, Executive Director, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at lisa@medicaled.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Onconova Therapeutics, Inc.

©2018 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.